Inspire Medical Systems INSP Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 85.4%+0.7pp | 84.7%+0.1pp | 84.5%+0.8pp | 83.8%-2.0pp | |
| Operating margin | 5.6%+1.1pp | 4.5%— | —— | -11.7%+5.4pp | |
| Net margin | 15.9%+9.3pp | 6.7%— | —— | -11.8%+6.2pp | |
| Returns | |||||
| Return on equity | 19.8%+11.3pp | 8.5%— | —— | -13.2%+5.1pp | |
| Return on invested capital | 8%+1.2pp | 6.7%— | —— | -78.9%-16.1pp | |
| Efficiency | |||||
| Asset turnover | 1.1×0.0× | 1.1×+0.1× | 1×+0.1× | 0.9×+0.1× | |
| Liquidity | |||||
| Current ratio | 6.1×-1.1× | 7.1×-0.5× | 7.6×-1.1× | 8.7×+2.2× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×-0.2× | |
| Net debt / EBITDA | -1.1×+1.7× | -2.8×— | —— | —— | |
| Per Share | |||||
| Book value per share | $26.25+16.3% | $22.58+15.6% | $19.54+10.6% | $17.67+110% | |
| Valuation | |||||
| Market capitalization | $1.24B-67.8% | $5.56B-7.5% | $6B-17.5% | $7.28B+15.6% | |
| Price / earnings | 9.5×-48.6× | 103.8×— | —— | —— | |
| Price / sales | 1.4×-3.2× | 6.9×-2.7× | 9.6×-8.2× | 17.8×-9.1× | |
| Price / book | 1.6×-4.5× | 8.1×-2.4× | 10.5×-4.2× | 14.7×-12.8× | |
| EV / EBITDA | 17.5×-48.1× | 127.5×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Inspire Medical Systems's profit margins?
- Inspire Medical Systems (INSP) runs a 85.8% gross margin and a 5.6% operating margin, with a 14.3% net margin.
- Where do Inspire Medical Systems's ratios come from?
- Every ratio is computed from Inspire Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
